4//SEC Filing
Lippa Arnold 4
Accession 0001493152-20-013399
CIK 0000849636other
Filed
Jul 14, 8:00 PM ET
Accepted
Jul 15, 9:14 PM ET
Size
11.6 KB
Accession
0001493152-20-013399
Insider Transaction Report
Form 4
Lippa Arnold
DirectorChairman, CEO and PresidentOther
Transactions
- Other
Series H Preferred Stock
2020-07-13+600→ 600 totalExercise: $0.01From: 2020-07-13Exp: 2023-09-30→ Conversion Units (93,750,000 underlying) - Gift
Series H Preferred Stock
2020-07-13+600→ 0 total(indirect: By Trust)Exercise: $0.01From: 2020-07-13Exp: 2023-09-30→ Conversion Units (93,750,000 underlying) - Gift
Series H Preferred Stock
2020-07-13−600→ 0 totalExercise: $0.01From: 2020-07-13Exp: 2023-09-30→ Conversion Units (93,750,000 underlying)
Footnotes (5)
- [F1]The full designation of this class of preferred stock is "Series H 2% Voting, Non-Participating, Convertible Preferred Stock".
- [F2]On July 13, 2020, Dr. Lippa agreed to forgive a portion of the accrued but unpaid compensation to which he was entitled pursuant to his employment agreement with RespireRx Pharmaceuticals Inc. (the "Company") equal to $600,000. On July 13, 2020, the Company issued to Dr. Lippa 600 shares of the Company's Series H 2% Voting, Non-Participating, Convertible Preferred Stock ("Series H Preferred Stock") in exchange for the forgiveness of $600,000 of accrued and unpaid compensation, which equates to a per share value of $1,000.00 per share.
- [F3]Each Conversion Unit consists of one share of the common stock of the Company, and one warrant exercisable into one share of the common stock of the Company (such warrant having an initial exercise price of $0.007 per share, and terminating on September 30, 2023).
- [F4]The disposition or acquisition, as applicable, reflects an estate planning transaction.
- [F5]Dr. Lippa gifted these securities into a family trust for the benefit of his spouse, daughter and grandchildren. Dr. Lippa is not the trustee, does not exercise voting or investment control over shares held in the trust, and disclaims beneficial ownership of the shares of Series H Preferred Stock owned by the trust, except to the extent of his pecuniary interest therein.
Documents
Issuer
RespireRx Pharmaceuticals Inc.
CIK 0000849636
Entity typeother
Related Parties
1- filerCIK 0001363763
Filing Metadata
- Form type
- 4
- Filed
- Jul 14, 8:00 PM ET
- Accepted
- Jul 15, 9:14 PM ET
- Size
- 11.6 KB